Gilead Sciences, Inc. (NASDAQ:GILD) Morgan Stanley 20th Annual Global Healthcare Conference September 13, 2022 10:35 AM ET Company Participants Daniel O'Day - Chairman & CEO William Grossman - SVP, Oncology Clinical Development Conference Call Participants Matthew Harrison - Morgan Stanley Matthew Harrison I think we're ready. So good morning, everybody. Thanks for joining us for the next session. I'm Matthew Harrison, one of the biotech analysts here at Morgan Stanley. Really pleased to have Gilead with u ...